ChemoMetec A/S (CHEMM.CO)
- Previous Close
282.40 - Open
286.20 - Bid 286.00 x --
- Ask 286.80 x --
- Day's Range
282.20 - 289.80 - 52 Week Range
255.00 - 554.00 - Volume
52,472 - Avg. Volume
122,813 - Market Cap (intraday)
4.988B - Beta (5Y Monthly) 1.20
- PE Ratio (TTM)
34.74 - EPS (TTM)
8.25 - Earnings Date May 8, 2024
- Forward Dividend & Yield 6.00 (2.09%)
- Ex-Dividend Date Oct 13, 2023
- 1y Target Est
462.50
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. In addition, the company provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
chemometec.comRecent News: CHEMM.CO
Performance Overview: CHEMM.CO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEMM.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEMM.CO
Valuation Measures
Market Cap
4.99B
Enterprise Value
4.76B
Trailing P/E
34.70
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.43
Price/Book (mrq)
10.00
Enterprise Value/Revenue
11.86
Enterprise Value/EBITDA
23.35
Financial Highlights
Profitability and Income Statement
Profit Margin
35.81%
Return on Assets (ttm)
19.61%
Return on Equity (ttm)
30.09%
Revenue (ttm)
401.54M
Net Income Avi to Common (ttm)
143.8M
Diluted EPS (ttm)
8.25
Balance Sheet and Cash Flow
Total Cash (mrq)
232.15M
Total Debt/Equity (mrq)
1.19%
Levered Free Cash Flow (ttm)
78.25M
Research Analysis: CHEMM.CO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: CHEMM.CO
CHEMM.CO does not have Company Insights